Want to set your company up for success from day one?

Build Your Bench:
How to Start & Scale a Biotech Company

A virtual event featuring biotech founders, investors, and scientists who share their strategies for lasting success

View the on-demand sessions and related resources below.

Hear from founders, investors, and industry experts as they share practical advice for building successful biotech companies

Highlight Reel
Welcome Address
Founders’ Panel: Tales from the Bench
Venture Capital Panel: Top Things to Know Before You Fundraise
Technology Focus: Building the Right Data Foundations
Make Your First Year Count: Practical Advice For Biotech Startups

"The best advice is to identify problems for which there are incremental valuable solutions along the way to your billion dollar solution."

David Nelles
Founder/CEO, U1 Bio

"We’re not just evaluating whether or not someone has a great technology. We’re evaluating whether or not they can be a great CEO."

Julie Grant
General Partner, Canaan

"It’s really hard but if you can tell your story well, you will raise money, and if you can’t tell your story well, you probably won’t."

Nicolas Tilmans
Founder/CEO, Anagenex

"I urge people to really think about their personal values and use them as your guideposts because they don't tend to change very much. Keep them in mind as you build relationships and your company."

Christian Cobaugh
Founder/CEO, Vernal Biosciences

"In our screening process, we often look for people who really have a fundamental desire to seek the truth around their science, their market, and the best way to build their company."

Alex Kopelyan
Senior Director/Partner, Indiebio at SOSV

“Surround yourself with people that you trust and respect — experts in the field. Where you can go wrong is by not building a good team. The story is important and the team is important. And you won’t know until you try, so just get out there.”

Ashok Bandaranayake
Co-Founder and VP of Immuno-Oncology, Link Immunotherapeutics

“Building a network of people across the world who have common interests will lead to many things you may not even anticipate at the time. Yet investing the time in building those relationships really does pay back in spades later on.”

Greg Yap
Partner, Menlo Ventures

“Fewer systems and technology partners in many ways is better because the challenge is getting everything integrated. If you have a bunch of different systems, getting them to talk to each other and data to flow appropriately together can be a massive part of the battle. Fewer systems can reduce the complexity of those challenges.”

Mason Victors
Chief Product Officer, Recursion Pharmaceuticals

“If you're a life sciences founder from academia, the importance of getting your IP on file and patent applications in order is crucial. Get help early from the tech transfer office at your university.”

Darren Cooke
Executive Director, UC Berkeley Life Sciences Entrepreneurship Center

“Start thinking early about the foundations of your company. You’re building amazing products and amazing businesses that help our world become a better place — but you need to make sure your foundation isn’t messy so that you can go build those products.”

Natasha Arora
Head of Law Firm & Service Provider Strategy, Carta

“It gets back to ease of use and reduced friction on day one. Yes, it may take a little bit more effort to do one or two more things upfront — but long term it’s absolutely going to be a good investment.”

Aaron Friedman
Principal Startup Solutions Architect, Healthcare and Life Sciences, Amazon Web Services

"Building a strong, scalable technology foundation will let you innovate faster and more effectively. It will help you create a secure collaboration platform with your partners and allow your R&D team to focus on science, innovation, and discoveries."

Karina Chmielewski
VP of Platform Operations, Third Rock Ventures

"Previously, only the largest global pharma would spend a year setting up a platform because they knew they could afford it and they could wait. Startups can't wait that long in order to execute. Platforms that are delivered as a service allow you to immediately experiment at scale."

Todd Crosslin
Global Head of Healthcare & Life Sciences, Snowflake

Related Resources

Blog Post
Build Your Bench: A Recap of Benchling’s Virtual Event
Whitepaper
4 Reasons For Growing Biotechs To Adopt A Could R&D Data Platform Now
Blog Post
Next-Gen Cell Therapy Built on Next-Gen Informatics from Day 1
CASE STUDY
Anagenex: Teaming up with a trailblazer to develop next-gen drug discovery
On-Demand Webinar
Building a Biotech: Introducing the New Benchling for Startups Program
Program
Benchling for Startups: Built and Priced for Early-Stage Biotechs

Want to set your company up for success from day one?

We can help. Book a demo with our team, and we’ll show you how we’ve helped hundreds of startups to scale.

Request Demo